Page last updated: 2024-11-05

trimethoprim and Mucocutaneous Lymph Node Syndrome

trimethoprim has been researched along with Mucocutaneous Lymph Node Syndrome in 1 studies

Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.

Mucocutaneous Lymph Node Syndrome: An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brettle, RP1
Gray, JA1
Sangster, G1
Murdoch, JM1
Dick, HM1

Other Studies

1 other study available for trimethoprim and Mucocutaneous Lymph Node Syndrome

ArticleYear
The mucocutaneous syndromes--Erythema multiforme, Stevens-Johnson and Ectodermosis erosiva pluriorificialis.
    The Journal of infection, 1982, Volume: 4, Issue:2

    Topics: Adolescent; Adult; Aged; Bacterial Infections; Child; Child, Preschool; Drug Combinations; Erythema

1982